All In Biotech

Drug Trial Radar · NCT07054684

Study of BHV-1400 in IgA Nephropathy

An Open-Label Biomarker Study of BHV-1400 in IgA Nephropathy

Last checked: Nov 20, 2026Latest source record: Jun 23, 2026 (this record)Source: ClinicalTrials.govMethods & limitations

Recruiting

Status

Recruiting

Enrollment

20

Planned (sponsor's estimate)

Start

Jul 30, 2025

Primary completion

Jul 2027

Study completion Jul 2027

Sponsor

Lead sponsor
Biohaven Therapeutics Ltd.Industry
Sponsor type
Industry
First posted
Jul 8, 2025

More drug trials from this sponsor

Design

Study type
Interventional
Phase
Phase 1
Allocation
Not applicable (single group)
Model
Single group
Masking
None
Primary purpose
Treatment
FDA-regulated drug
Yes
Who can join
All sexes, from 18 years, up to 65 years
Healthy volunteers
No

Summary

As written by the sponsor on the registry.

The purpose of this study is to determine if BHV-1400 is a safe and tolerable treatment in participants with IgA Nephropathy (IgAN).

Conditions

  • IgA Nephropathy

Interventions

  • BHV-1400Drug

    BHV-1400 is delivered subcutaneously (SC)

Primary outcomes

What the sponsor says the trial is designed to measure.

  1. Number of participants with Serious AEs (SAEs), AEs leading to discontinuation, deathsTime frame: Up to 1 year
  2. Number of participants with Grade 3-4 treatment-emergent laboratory abnormalitiesTime frame: Up to 1 year

Locations

15 sites in 2 countries. Site status is shown where the registry gives one.

  • Site-001

    Farmington, Connecticut · Recruiting

  • Site-003

    Miami Lakes, Florida · Recruiting

  • Site-011

    Miami Lakes, Florida · Recruiting

  • Site-013

    Orlando, Florida · Recruiting

  • Site-005

    Pembroke Pines, Florida · Recruiting

  • Site-008

    Lawrenceville, Georgia · Recruiting

  • Site-009

    Hinsdale, Illinois · Recruiting

  • Site-012

    Indianapolis, Indiana · Recruiting

  • Site-015

    Shelby, Michigan · Recruiting

  • Site-006

    Chesterfield, Missouri · Recruiting

  • Site-002

    Dakota Dunes, South Dakota · Recruiting

  • Site-014

    Houston, Texas · Recruiting

  • Site-004

    Houston, Texas · Recruiting

  • Site-016

    Salt Lake City, Utah · Recruiting

  • Site-007

    Leicester, United Kingdom · Recruiting

Contact details for sites and study staff are not shown here. To ask about taking part, use the contact information on the registry record.

For information only. Nothing on this page is investment, legal, tax or medical advice, and nothing here is an offer to sell or a solicitation of an offer to buy any security. The data comes from public government sources, which can be incomplete, delayed or wrong. Check the original record before relying on it.